Can Hyderabad Evolve into the Global Life Sciences Capital?
Synopsis
Hyderabad is on the brink of transformation, with Chief Minister A. Revanth Reddy asserting its potential to become the world's life sciences capital. At BioAsia 2026, he shared insights on the city's advancements, investments, and its growing reputation in the global biotech landscape.
Key Takeaways
Hyderabad is transitioning to a global life sciences capital.
Over Rs 73,000 crore in investments have been secured in the past two years.
Participation from over 4,000 delegates at BioAsia 2026 highlights global interest.
The region aims for $25 billion in life sciences investments by 2030.
Significant advancements in AI and gene editing are underway.
Hyderabad, Feb 17 (NationPress) The Chief Minister of Telangana, A. Revanth Reddy, remarked on Tuesday that Hyderabad possesses the capability to evolve from the global vaccine capital to the epicenter of life sciences worldwide.
While inaugurating BioAsia 2026 alongside IT & Industries Minister D. Sridhar Babu, he emphasized that this annual event exemplifies Hyderabad's achievements as a prominent hub for life sciences.
He expressed optimism that BioAsia would gain recognition akin to the World Economic Forum held in Davos.
The Chief Minister underscored Telangana's distinct advantages that will facilitate its transformation from a global vaccine powerhouse to a leader in life sciences, including a robust vision, well-defined policies, an abundance of highly skilled professionals, and leading educational institutions.
Hyderabad is recognized as a premier center for Global Capability Centres (GCCs), excelling in research and design.
He highlighted several recent initiatives, such as the unveiling of the Telangana Next-Gen Life Sciences Policy at Davos, the expansion of Genome Valley, the introduction of 1Bio for cutting-edge research and innovation, the advancement of Green Pharma City, and the establishment of multiple global capability centers in Hyderabad.
"In the past two years, we have attracted investments exceeding Rs 73,000 crore in life sciences," he stated.
Hyderabad stands out as a prime location for setting up GCCs, fostering innovation, designing molecules and drugs, managing clinical analytics, creating AI platforms, and advancing digital manufacturing.
Given the impressive turnout at BioAsia from across the globe, the Chief Minister suggested that the conference might evolve beyond its current name to become Bio-World.
He emphasized the presence of leading thinkers and business moguls in pharmaceuticals, biosciences, biotech, bulk drugs, vaccines, and healthcare in Hyderabad.
He asserted that Hyderabad has established a reliable, stable, and future-ready ecosystem. "From bulk drugs to biologics, from manufacturing to innovation, Telangana is elevating its position on the value chain," he stated.
Minister Sridhar Babu added that the state aims for $25 billion in life sciences investments and the creation of 500,000 jobs by 2030, with a strategic plan to rank Telangana among the top three life sciences clusters globally. "Telangana is transitioning from supply-driven manufacturing to solution-oriented global leadership by developing a ready-to-work talent pool in mRNA, gene editing, and AI-driven drug discovery while reinforcing Hyderabad as a center for next-gen innovation and medical tourism," he mentioned.
BioAsia 2026 witnessed participation from over 4,000 delegates representing 500 leading companies within the life sciences ecosystem worldwide.
The Chief Minister awarded Prof. Bruce Levine from the University of Pennsylvania with the Genome Valley Excellence Award.
Point of View
I see Hyderabad's aspirations as a pivotal step in India's growth story. The strong investments and innovations in life sciences signify not just a regional shift but a potential global impact, positioning Telangana as a leader in biotech and healthcare.
NationPress
10 May 2026
Frequently Asked Questions
How much investment has Telangana received in life sciences?
Telangana has attracted investments exceeding Rs 73,000 crore in the life sciences sector over the past two years.
What are Global Capability Centres (GCCs)?
GCCs are centers established by companies to leverage global talent and innovation, focusing on research, design, and operational excellence.
What is the future goal for Telangana in life sciences?
The state aims for $25 billion in life sciences investments and the creation of 500,000 jobs by 2030, aspiring to rank among the top three life sciences clusters globally.
Who received the Genome Valley Excellence Award?
Prof. Bruce Levine from the University of Pennsylvania was honored with the Genome Valley Excellence Award at BioAsia 2026.
